Generally, EGFR overexpression in gliomas has been mainly recognized to gene amplification, the activating mutation EGFRvIII, and gene fusion events, which overall comprise approximately half of GBM and are rarely observed in LGG [59,60]. Here, EGFR is linked to central nervous system cancer.